Search

everythinglearnresearchcommunity

for

Search:↓

A 73-year-old woman with Hypopigmented Mycosis Fungoides, a rare skin lymphoma, experienced disease progression despite treatment, emphasizing the need for ongoing monitoring.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

COVID-19-positive patients with prosthetic speech implants face increased risks and need special care.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Co-trimoxazole may help treat autoimmune diseases.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

The document concludes that misdiagnosis in skin conditions is common, certain treatments can cause allergic reactions, and some skin symptoms are linked to leukemia, especially in certain Japanese regions.

Post-COVID, many patients experience skin issues like hair loss and herpes reactivation, especially in middle-aged women.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

The document summarizes skin and immune system disease findings, especially related to AIDS, from the 1980s.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Childhood cancer survivors need better skin care and sun protection.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Remote monitoring of chronic diseases like dermatomyositis is challenging and needs better tools for early detection and patient education.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.